Medindia

X

TB Treatment Time Significantly Reduced by New Regimen, Says CDC

by Kathy Jones on  May 17, 2011 at 10:10 PM Drug News   - G J E 4
Centers for Disease Control and Prevention (CDC) officials have said that a new regimen for treatment of latent tuberculosis significantly reduces the duration of the same.
 TB Treatment Time Significantly Reduced by New Regimen, Says CDC
TB Treatment Time Significantly Reduced by New Regimen, Says CDC
Advertisement

Latent tuberculosis is a condition where the patients do have TB, but are not capable of passing on the infection to other people. "New, simpler ways to prevent TB disease are urgently needed, and this breakthrough represents one of the biggest developments in TB treatment in decades," CDC Director Dr. Tom Frieden said, in a statement.

Advertisement
Conventional treatment for latent TB included taking a special pill called isoniazid once daily for a period of nine months. However in a new federal trial, 8,000 people with latent TB in the United States, Canada, Brazil and Spain were treated with either 300 milligrams of isoniazid once daily for nine months or 900-milligram dose of isoniazid and a 900 milligram dose of rifapentine.

The best thing was that they needed to take the pills just once a week and not on a daily basis. Around 15 cases of TB developed in people on the standard treatment, compared with seven cases in people on the new treatment.

The researchers said follow-up studies were needed to assess the efficacy of the new regimen.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All